Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)

SIMPLE SUMMARY: Until recently the outcome for women with advanced endometrial carcinoma has been poor. New immune therapies have resulted in much better outcomes for some, but not all, women with advanced disease. Determining which women are likely to respond is important, both to identify potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Deborah, Robledo, Kristy P., Yip, Sonia, Cummins, Michelle M., Kok, Peey-Sei, Lee, Yeh Chen, Friedlander, Michael, Baron-Hay, Sally, Shannon, Catherine, Coward, Jermaine, Beale, Philip, Goss, Geraldine, Meniawy, Tarek, Lombard, Janine, Spurdle, Amanda B., Andrews, John, Stockler, Martin R., Mileshkin, Linda, Antill, Yoland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818816/
https://www.ncbi.nlm.nih.gov/pubmed/36612250
http://dx.doi.org/10.3390/cancers15010254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818816/
https://www.ncbi.nlm.nih.gov/pubmed/36612250
http://dx.doi.org/10.3390/cancers15010254

Ejemplares similares